Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2022 –2029 | |
|
|
USD 796.51 Million |
| USD 1,682.71 Million | |
| % | |
|
Global Sterility Indicators Market, By Type (Chemical, Biological), Techniques (Heat, Low Temperature, Filtration, Radiation, Liquid), End-User (Hospitals, Pharmaceutical Companies, Medical device Companies, Clinical laboratories/Research Centers, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
The sterility indicators market is expected to grow at a rapid pace in the next few years. The market is predicted to grow due to an increase in the geriatric population, an increase in the number of infections around the world, an increase in research and development efforts, and an increase in hospital-acquired illnesses. Furthermore, the market is likely to be driven by a growth in the number of sterilisation operations, new and enhanced sterility indicators, and increased demand for medical devices and medications.
Data Bridge Market Research analyses that the sterility indicators market which was USD 796.51 million in 2021, would rocket up to USD 1682.71 million by 2029, and is expected to undergo a CAGR of 9.80% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Chemical, Biological), Techniques (Heat, Low Temperature, Filtration, Radiation, Liquid), End-User (Hospitals, Pharmaceutical Companies, Medical device Companies, Clinical laboratories/Research Centers, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
3M (U.S), Anderson Products, Inc. (U.S), H.W.Andersen Products Ltd. (U.S), Cardinal Health (U.S), Getinge AB (Sweden), gke-GmbH (Germany), Hu-Friedy Mfg. Co., LLC (U.S), Matachana Group (U.S), Mesa Labs, Inc. (U.S), Propper Manufacturing Co., Inc. (U.S), Steris (U.S), Cantel Medical (U.S)
|
|
Market Opportunities
|
|
Market Definition
Sterility indicators are intended to indicate or define the efficiency of any sterilization process. Sterilization is a method of killing all forms of life and other foreign or biological agents such as bacteria, viruses, fungus, prions, spore forms, and other organisms in a specific region or location. Chemicals, heat, high pressure, irradiation, and filtration are all examples of sterilisation methods. Biological, mechanical, and chemical sterility indicators must be used to monitor sterilisation methods. Sterilization procedures need to be monitored using sterility indicators such as biological, mechanical, and chemical sterility indicators.
Drivers
R&D is expected to drive demand for various sterilising processes in the biotechnology and pharmaceutical industries. Pharmaceutical items and packing equipment must be sterilised to eliminate all forms of microbiological life and safeguard against contamination. Stem sterilisation is receiving a lot of traction due to its effectiveness, which is helping the market grow.
Aside from these factors, an increase in the number of cases of hospital-acquired infections is forcing market vendors to expand their production rates to fulfill demand from the booming healthcare industry. Infections acquired in hospitals are known to worsen the condition of previously admitted patients. This has boosted the use of hospital sterile processing around the world. The increase in the number of sterilisation treatments is expected to positively impact market growth.
New and enhanced sterility indicators are expected to lower the prices of earlier versions, assisting the market to attain new heights. The industry is being fueled by an increase in the number of infections around the world. Furthermore, the industry is likely to benefit from a rise in the geriatric population. Due to their lower immunity, older people are more prone to become unwell, which will certainly create money for the market.
Opportunities
The market is growing due to rising demand for medications and medical equipment around the world as the prevalence of chronic diseases rises. Sterilization's growing use in the pharmaceutical and packaging industries to assure sanitation, kill microbiological life, and avoid contamination are further driving market expansion. Furthermore, rising healthcare spending and tight government regulation in terms of sanitary and safety across all healthcare sectors are propelling the market forward.
Restraints/Challenges
However, sterility indicator equipment flaws such as the inability to detect procedural problems such as overloading the steriliser, difficult package configuration in the load, improper sterilisation equipment, non-compliance with sterilisation standards, high costs associated with devices, and chemical exposure can stymie market growth.
This sterility indicators market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sterility indicators market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The global sterility indicators market is expected to be valued USD 879.8 million in 2022 due to the COVID-19 pandemic, and USD 1420.3 million by 2028 with a CAGR of 8.3% throughout the research period. Sterilization surgical theatres, nursing homes, hospices, doctors' offices, clinics, and hospitals are all places where equipment is employed. Sterilization is commonly required for surgical treatments, while it can be done as an outpatient procedure in some situations. In intensive care and rehabilitation units and public healthcare facilities such as clinics and hospitals, sterilisation is required to prevent bacterial contamination in both people and animals. Regardless of these factors, there remain certain challenges that can negatively affect growth of the market.
The sterility indicators market is segmented on the basis of type, technique and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Types
Techniques
End-User
The sterility indicators market is analysed and market size insights and trends are provided by country, type, technique, and end-user as referenced above.
The countries covered in the sterility indicators market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominating the global sterility indicators market due to high demand from regular product introductions in drugs, medical devices, and biologics and reimbursement coverage are some of the drivers driving this region's growth. The regional demand for medical items is being fueled by an ever-increasing target patient population due to ageing.
Asia-Pacific is expected to exhibit the fastest CAGR during the forecast period 2022 to 2029. Local manufacturers are well-represented in China and India, providing cost-effective options and increasing rivalry. Furthermore, the developing medical tourism business in the region is likely to lure the target patient population to Asia-Pacific due to the availability of modern healthcare treatments at a low cost.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The sterility indicators market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for sterility indicators market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the sterility indicators market. The data is available for historic period 2010-2020.
The sterility indicators market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to sterility indicators market.
Some of the major players operating in the sterility indicators market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.